B-intervention	0	3	Web
I-intervention	3	4	-
I-intervention	4	9	based
I-intervention	10	19	proactive
I-intervention	20	26	system
O	27	29	to
O	30	37	improve
O	38	44	breast
O	45	51	cancer
O	52	61	screening
O	61	62	:
O	63	64	a
O	65	75	randomized
O	76	86	controlled
O	87	92	trial
O	92	93	.

O	94	103	Screening
O	104	115	mammography
O	116	118	is
O	119	130	recommended
O	131	134	for
O	135	140	early
O	141	150	detection
O	151	153	of
O	154	160	breast
O	161	167	cancer
O	168	171	but
O	172	181	screening
O	182	187	rates
O	188	194	remain
O	195	205	suboptimal
O	205	206	.

O	207	208	A
O	209	216	primary
O	217	221	care
O	222	228	portal
O	229	232	for
O	233	234	a
O	235	240	large
O	241	249	academic
O	250	257	primary
O	258	266	practice
O	267	270	was
O	271	280	developed
O	281	284	for
O	285	288	all
O	289	299	preventive
O	300	308	services
O	308	309	.

O	310	317	Another
O	318	321	Web
O	321	322	-
O	322	327	based
O	328	334	system
O	335	336	(
O	336	344	PRECARES
O	345	346	[
O	346	356	PREventive
O	357	361	CAre
O	362	370	REminder
O	371	377	System
O	377	378	]
O	378	379	)
O	380	383	was
O	384	393	developed
O	394	397	for
O	398	409	appointment
O	410	421	secretaries
O	422	424	to
O	425	431	manage
O	432	441	proactive
O	442	448	breast
O	449	455	cancer
O	456	465	screening
O	465	466	.

O	467	473	Female
O	474	482	patients
O	483	487	aged
B-age	488	490	40
I-age	491	493	to
I-age	494	496	75
I-age	497	502	years
O	503	507	were
O	508	516	randomly
O	517	525	assigned
O	526	528	to
O	529	530	a
B-control	531	538	control
I-control	539	544	group
I-control	545	546	(
I-control	546	551	usual
I-control	552	556	care
I-control	556	557	)
O	558	561	and
O	562	564	an
O	565	577	intervention
O	578	583	group
O	583	584	.

O	585	588	For
O	589	592	the
O	593	605	intervention
O	606	611	group
O	611	612	,
O	613	614	2
O	615	622	monthly
O	623	630	letters
O	631	639	inviting
O	640	648	patients
O	649	651	to
O	652	659	undergo
O	660	671	mammography
O	672	676	were
O	677	681	sent
O	682	690	starting
O	691	692	3
O	693	699	months
O	700	706	before
O	707	711	they
O	712	716	were
O	717	720	due
O	721	724	for
O	725	731	annual
O	732	741	screening
O	741	742	,
O	743	751	followed
O	752	754	by
O	755	756	a
O	757	766	telephone
O	767	771	call
O	772	774	to
O	775	788	nonresponding
O	789	797	patients
O	797	798	.

O	799	800	A
O	801	809	subgroup
O	810	812	of
O	813	818	women
O	819	828	employees
O	829	832	was
O	833	840	further
O	841	851	randomized
O	852	854	to
O	855	862	receive
O	863	864	a
O	865	873	reminder
O	874	876	by
O	877	883	either
O	884	886	US
O	887	891	mail
O	892	894	or
O	895	896	e
O	896	897	-
O	897	901	mail
O	901	902	.

O	903	905	Of
O	906	909	the
O	910	915	total
O	916	924	eligible
O	925	935	population
O	936	938	of
B-total-participants	939	943	6665
O	944	949	women
O	950	960	identified
O	961	963	as
O	964	970	having
O	971	980	consented
O	981	983	to
O	984	995	participate
O	996	998	in
O	999	1007	research
O	1007	1008	,
B-intervention-participants	1009	1013	3339
O	1014	1018	were
O	1019	1027	randomly
O	1028	1036	assigned
O	1037	1039	to
O	1040	1043	the
O	1044	1051	control
O	1052	1057	group
O	1058	1061	and
B-control-participants	1062	1066	3326
O	1067	1069	to
O	1070	1073	the
O	1074	1086	intervention
O	1087	1092	group
O	1092	1093	.

O	1094	1097	The
B-outcome	1098	1107	screening
I-outcome	1108	1112	rate
I-outcome	1113	1116	for
I-outcome	1117	1123	annual
I-outcome	1124	1135	mammography
O	1136	1139	was
B-iv-bin-percent	1140	1142	64
I-iv-bin-percent	1142	1143	.
I-iv-bin-percent	1143	1144	3
I-iv-bin-percent	1144	1145	%
O	1146	1149	for
O	1150	1153	the
O	1154	1166	intervention
O	1167	1172	group
O	1173	1176	and
B-cv-bin-percent	1177	1179	55
I-cv-bin-percent	1179	1180	.
I-cv-bin-percent	1180	1181	3
I-cv-bin-percent	1181	1182	%
O	1183	1186	for
O	1187	1190	the
O	1191	1198	control
O	1199	1204	group
O	1205	1206	(
O	1206	1207	P
O	1208	1209	<
O	1209	1210	.
O	1210	1213	001
O	1213	1214	)
O	1214	1215	.

O	1216	1221	There
O	1222	1226	were
O	1227	1229	no
O	1230	1241	significant
O	1242	1253	differences
O	1254	1261	between
O	1262	1265	the
O	1266	1267	2
O	1268	1274	groups
O	1275	1278	for
O	1279	1282	any
O	1283	1285	of
O	1286	1289	the
O	1290	1295	other
O	1296	1301	adult
O	1302	1312	preventive
O	1313	1321	services
O	1321	1322	.

O	1323	1326	For
O	1327	1330	the
O	1331	1339	employee
O	1340	1348	subgroup
O	1348	1349	,
O	1350	1353	the
B-outcome	1354	1363	screening
I-outcome	1364	1368	rate
O	1369	1372	was
B-cv-bin-percent	1373	1375	57
I-cv-bin-percent	1375	1376	.
I-cv-bin-percent	1376	1377	5
I-cv-bin-percent	1377	1378	%
O	1379	1382	for
O	1383	1386	the
O	1387	1394	control
O	1395	1400	group
O	1400	1401	,
B-iv-bin-percent	1402	1404	68
I-iv-bin-percent	1404	1405	.
I-iv-bin-percent	1405	1406	1
I-iv-bin-percent	1406	1407	%
O	1408	1411	for
O	1412	1415	the
O	1416	1418	US
O	1419	1423	mail
O	1424	1429	group
O	1429	1430	,
O	1431	1434	and
B-iv-bin-percent	1435	1437	72
I-iv-bin-percent	1437	1438	.
I-iv-bin-percent	1438	1439	2
I-iv-bin-percent	1439	1440	%
O	1441	1444	for
O	1445	1448	the
O	1449	1450	e
O	1450	1451	-
O	1451	1455	mail
O	1456	1461	group
O	1462	1463	(
O	1463	1475	intervention
O	1476	1478	vs
O	1479	1486	control
O	1486	1487	,
O	1488	1489	P
O	1490	1491	<
O	1491	1492	.
O	1492	1495	001
O	1495	1496	;
O	1497	1498	e
O	1498	1499	-
O	1499	1503	mail
O	1504	1506	vs
O	1507	1509	US
O	1510	1514	mail
O	1514	1515	;
O	1516	1517	P
O	1518	1519	=
O	1520	1521	.
O	1521	1523	24
O	1523	1524	)
O	1524	1525	.

O	1526	1529	The
O	1530	1536	breast
O	1537	1543	cancer
O	1544	1553	screening
O	1554	1558	rate
O	1559	1567	improved
O	1568	1581	significantly
O	1582	1586	with
O	1587	1590	the
O	1591	1599	practice
O	1600	1608	redesign
O	1609	1611	of
O	1612	1618	having
O	1619	1630	appointment
O	1631	1642	secretaries
O	1643	1654	proactively
O	1655	1661	manage
O	1662	1668	breast
O	1669	1675	cancer
O	1676	1685	screening
O	1686	1691	needs
O	1691	1692	.
